ACLY-IN-2 (Compound 7) has inhibitory effect against human ATP citrate lyase (hACLY), with an IC50 of less than 1 nM. ACLY-IN-2 can be studied in research on liver-related diseases, type-2 diabetes, autoimmunity, and cancer[1].
Molecular Weight:
481.85
CAS Number:
[3009136-86-8]
Formula:
C21H14ClF2NO6S
Target:
ATP Citrate Lyase
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted